Roger D. Dansey
Director · INOVIO PHARMACEUTICALS, INC.
Individual
- 2025
- May 21, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Roger D. Dansey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Ring - $3.33M in NRIX purchases and sales in the last 12 months
- Houte Hans van - $635K in NRIX purchases and sales in the last 12 months
- Gwenn Hansen - $522K in NRIX purchases and sales in the last 12 months
- Kevin Lee - $98K in BCYC purchases and sales in the last 12 months
- Michael Skynner - $31K in BCYC purchases and sales in the last 12 months
- Michael Charles Ferguson Hannay - $23K in BCYC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Roger D. Dansey?
Roger D. Dansey is a corporate insider, tracked as Director of INOVIO PHARMACEUTICALS, INC. (INO). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Roger D. Dansey last file a Form 4?
The most recent primary Form 4 on record is dated 21 May 2026, one of 5 filings going back to 2025.
